ESMO Academy 2016: Programme

ESMO strives to deliver excellence in education and to develop valuable educational resources and meetings which accompany oncologists throughout all career stages.

With the rising incidence of cancer cases and the rapid changes taking place in oncology, it is vital for professionals to remain up to date.

Access the ESMO Academy 2016 Programme Download the Programme (PDF)

Main themes for the ESMO Academy 2016

The ESMO Academy 2016 was designed as a preparation course for the ESMO Examination and for medical oncologists in need of a refresher course. Expert speakers offered a general overview of:

  • Colorectal Cancer
  • Prostate Cancer
  • Sarcoma & GIST
  • Lung Cancer
  • Breast Cancer
  • Gynaecological Cancer
  • Renal & Testicular Cancer
  • Melanoma
  • Head & Neck Cancer
  • Brain Tumours
  • Haematology & Lymphoma
  • Pharmacokinetics & Drug Interactions
  • Upper GI & Non-Colorectal Cancer

The format was highly interactive and facilitated face to face contact with the experts.

Target Audience

Medical Oncology:

  • Residents / Trainees / Fellows
  • Practitioners who were preparing the ESMO Examination or were interested in a general overview across tumour types

Conference objectives

  • To understand the examination process and questions format
  • To learn/update participants about the current standard of care for the main malignancies and the supporting clinical trials
  • To learn about the pharmacokinetics of systemic therapies for the management of cancer and the interactions of these drugs
  • To identify gaps in an individual’s knowledge for review and improvement
  • To learn from the integrated assessments and question reviews with individual speakers and the speaker panel

Travel grants

Attendees registered for the 2016 ESMO Examination could also apply for financial support for travel to Oxford.

Webcasts

The ESMO Academy webcasts include all sessions of the official programme where speaker permission is granted. ESMO members can also access the webcast via OncologyPRO.